Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 540(1-3): 175-82, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16716292

ABSTRACT

The aim of this study was to evaluate the effect of angiotensin II on models of acute inflammation. This study shows that angiotensin II potentiates the carrageenan- and dextran-induced paw edema. The administration of angiotensin II does not change the myeloperoxidase activity, neither the tissue content of interleukin-1 beta and tumor necrosis alpha nor the neutrophil migration to the peritoneal cavity, but induces significant enhancement of mast cell degranulation. The anti-histamine, mepyramine, and the anti-serotonin, metisergyde, reduce the angiotensin II-facilitated dextran-induced edema. Our results suggest that angiotensin II increases the vascular permeability through induction of mast cell degranulation and that this effect is mediated by the angiotensin AT2 receptor, since the angiotensin AT1 receptor antagonist and the angiotensin AT2 receptor agonist potentiated the paw edema.


Subject(s)
Angiotensin II/toxicity , Inflammation/chemically induced , Mast Cells/physiology , Acute Disease , Animals , Anti-Allergic Agents/pharmacology , Carrageenan/toxicity , Cell Degranulation/drug effects , Cell Movement/drug effects , Dextrans/toxicity , Drug Synergism , Edema/chemically induced , Edema/metabolism , Edema/prevention & control , Hindlimb/drug effects , Hindlimb/metabolism , Hindlimb/pathology , Inflammation/pathology , Inflammation/physiopathology , Interleukin-1beta/metabolism , Neutrophils/drug effects , Neutrophils/pathology , Peritoneal Cavity/pathology , Peroxidase/metabolism , Pyrilamine/pharmacology , Rats , Rats, Wistar , Time Factors , Tumor Necrosis Factor-alpha/metabolism , Vasoconstrictor Agents/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...